ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase study tests whether combining two experimental antibodies (JNJ-87189401 and JNJ-78278343) can help control advanced prostate cancer that has spread or is no longer responding to standard treatments. About 355 men with advanced prostate cancer will take part. The …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 03:23 UTC
-
Five shots of radiation could tame advanced prostate cancer
Disease control Recruiting nowThis study tests a shorter, high-dose radiation treatment (SBRT) given in just 5 sessions for people with advanced or high-risk prostate cancer. The goal is to see if it is safe and works well. About 70 participants will be enrolled at MD Anderson Cancer Center.
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New drug combo targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests two experimental drugs, HS-20093 and HRS-5041, together in men with advanced prostate cancer that has stopped responding to standard hormone therapy. The goal is to find the safest dose and understand side effects. About 63 participants will take part in this ear…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for advanced prostate cancer: experimental drug RO7656594 enters human trials
Disease control Recruiting nowThis early-stage trial tests a new drug called RO7656594 in people with advanced or metastatic prostate cancer. The goal is to check its safety, find the right dose, and see if it can help control the disease. About 210 participants will take part in this study.
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New scan spots prostate cancer that standard tests miss
Diagnosis Recruiting nowThis study tests whether a special PET scan using 18F-fluciclovine can better detect advanced prostate cancer that doesn't show up well on standard PSMA scans. About 30 people with metastatic prostate cancer that has low PSMA levels or neuroendocrine features will get the scan an…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated May 18, 2026 12:02 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThis study tests a telehealth program called ENGAGE for people with stage IV breast, prostate, lung, or colorectal cancer. The program helps manage symptoms like pain, fatigue, and distress that interfere with daily life. About 190 participants will be randomly assigned to ENGAGE…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 26, 2026 03:21 UTC
-
New imaging study could change how we track advanced prostate cancer
Knowledge-focused Recruiting nowThis study is for men with advanced prostate cancer. It uses two different PET scans (PSMA and FDG) to get a clearer picture of the cancer's biology at different stages and during treatment. The goal is to learn how these scans might help doctors choose better treatments and moni…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 26, 2026 03:23 UTC
-
Lab-Grown Mini-Tumors could personalize prostate cancer care
Knowledge-focused Recruiting nowThis study aims to improve how doctors choose treatments for aggressive prostate cancer. Researchers will grow 3D mini-tumors from patient samples and test different therapies on them to see which works best. The goal is to find the most effective lab technique for predicting ind…
Matched conditions: ADVANCED PROSTATE CANCER
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated May 18, 2026 11:58 UTC